7 research outputs found

    Incommensurate ground state of double-layer quantum Hall systems

    Full text link
    Double-layer quantum Hall systems possess interlayer phase coherence at sufficiently small layer separations, even without interlayer tunneling. When interlayer tunneling is present, application of a sufficiently strong in-plane magnetic field B∥>BcB_\parallel > B_c drives a commensurate-incommensurate (CI) transition to an incommensurate soliton-lattice (SL) state. We calculate the Hartree-Fock ground-state energy of the SL state for all values of B∥B_\parallel within a gradient approximation, and use it to obtain the anisotropic SL stiffness, the Kosterlitz-Thouless melting temperature for the SL, and the SL magnetization. The in-plane differential magnetic susceptibility diverges as (B∥−Bc)−1(B_\parallel - B_c)^{-1} when the CI transition is approached from the SL state.Comment: 12 pages, 7 figures, to be published in Physical Review

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

    High-sensitive superconducting magnetometry on a two-dimensional electron gas up to 10 Tesla

    No full text
    We report on new magnetization studies on a two-dimensional electron system (2DES) revealing spin splitting of the Landau levels. For this, we have built a high-sensitive susceptometer consisting of a low-noise thin-film dc superconducting quantum interference device (SQUID) with a multiturn input coil and a wire-wound first-order gradiometer. The system noise level is only 40×10 −6 Φ 0 /√ (Hz) down to a frequency of a few Hz in unshielded environment. In background fields up to 10 T, the system exhibits significant low-frequency noise. At frequencies above 1 kHz, however, the SQUID sensitivity is barely affected and we have reached a value of about 10 −14 J/T at 1 T and better than 10 −13 J/T at 10 T. With this, we have studied the de Haas–van Alphen effect for a tunable 2DES starting from zero carrier density

    The Changing Landscape for Stroke\ua0Prevention in AF

    No full text

    The Changing Landscape for Stroke Prevention in AF

    No full text
    corecore